GE HealthCare Technologies Inc.
GEHC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $20 | $20 | $18 | $18 |
| % Growth | 0.6% | 6.6% | 4.3% | – |
| Cost of Goods Sold | $11 | $12 | $11 | $10 |
| Gross Profit | $8 | $8 | $7 | $7 |
| % Margin | 41.7% | 40.5% | 39.1% | 40.8% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $4 | $4 | $4 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $6 | $5 | $5 | $4 |
| Operating Income | $3 | $2 | $3 | $3 |
| % Margin | 13.3% | 12.5% | 13.8% | 15.9% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | $0 |
| Pre-Tax Income | $3 | $2 | $3 | $3 |
| Tax Expense | $1 | $1 | $1 | $1 |
| Net Income | $2 | $2 | $2 | $2 |
| % Margin | 10.1% | 8% | 10.4% | 12.8% |
| EPS | 4.37 | 3.04 | 4.22 | 4.9 |
| % Growth | 43.8% | -28% | -13.9% | – |
| EPS Diluted | 4.34 | 3.02 | 4.22 | 4.9 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | $4 | $4 | $3 | $4 |
| % Margin | 18.6% | 18% | 17.3% | 20.1% |